FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year
22 déc. 2021 16h05 HE
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol)...
CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference
21 déc. 2021 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
Global Oncology/Cancer Drugs Market to Grow $274.40 Billion by 2030
13 déc. 2021 03h33 HE
|
Allied Market Research
Portland, OR, Dec. 13, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Oncology/Cancer Drugs Market was accounted for $135.49 billion in 2020, and is...
Medical Tourism Market Projected to Garner a Revenue of $149.34 Billion by 2026, Growing at a CAGR of 12.4% from 2019-2026 [140-Pages] | Reveals by Research Dive
08 déc. 2021 09h00 HE
|
Research Dive
New York, USA, Dec. 08, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to garner a revenue of $149.34 billion by 2026 and...
Integer Holdings Corporation Completes Acquisition of Oscor, Inc.
02 déc. 2021 08h30 HE
|
Integer Holdings Corporation
PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of...
CVRx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
16 nov. 2021 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 16, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
CVRx Reports Third Quarter 2021 Financial and Operating Results
04 nov. 2021 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
Regenerative Medicine Market Size & Share 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
04 nov. 2021 06h00 HE
|
Graphical Research
Pune, India, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The global regenerative medicine market size is anticipated to show tremendous growth during the forecast timeframe, owing to rising number of...
CVRx to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call
21 oct. 2021 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
21 oct. 2021 07h30 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and...